JCE School of Medicine Faculty Present Research at the National IDeA Meeting

Every two years the National IDeA Symposium of Biomedical Research Excellence (NISBRE) meeting is held in Washington D.C. to bring together faculty, fellows and students that participate in the National Institutes of Health’s Institutional Development Award (IDeA) programs. This year the NISBRE meeting was held June 25-27, 2012 at the Benja Lamyaithong Marshall INBRE studentOmni Shoreham Hotel and was attended by six faculty members from the Joan C. Edwards School of Medicine, Marshall University in the West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) program, three from West Virginia University and one each from Bluefield State College, Concord College, West Virginia State University, West Virginia Wesleyan College and the University of Charleston. Several of the Marshall University faculty presented research during the meeting including Drs. Monica Valentovic, Nalini Santanam Nalini Santanam, Ph.D./M.P.H.and Travis Salisbury from the Department of Pharmacology, Physiology and Toxicology and Dr. Donald Primerano from the Department of Biochemistry and Microbiology. Also presenting research was Andre Benja Lamyaithong, an undergraduate student at Wheeling Jesuit University, who has been conducting research on antidotes for acetaminophen overdose with Dr. Valentovic for two summers as part of the West Virginia INBRE summer research program. Other JCE School of Medicine faculty members attending the meeting were: Dr. Jim Denvir, Department of Biochemistry and Microbiology, who co-authored the work with Dr. Primerano; and Dr. Gary Rankin, Department of Pharmacology, Physiology and Toxicology, who is a member of the Executive Planning Committee for the NISBRE meeting. 

 

Monica Valentovic, Ph.D.Dr.Valentovic’s research on how a component of grapes and red wine (resveratrol) can reduce damage to the kidney caused by a commonly used drug (cisplatin) to treat cancer was presented in a regular research session and highlighted in a special session on clinical and translational research. In addition, Dr. Primerano’s research into the genetics of families with high blood cholesterol was highlighted in a special session on cardiovascular disease.

The IDeA program was started in 1993 to help increase the biomedical research competitiveness in states that receive only small amounts of research funding from the National Institutes of Health. The IDeA program is composed of two award programs, one (Centers Of Biomedical Research Excellence; COBRE) that is designed to create centers with a biomedical research focus at larger research schools and a second program (INBRE) designed to build the biomedical research infrastructure at smaller colleges and universities and provide biomedical research training primarily to undergraduate students.Travis Salisbury, Ph.D. Currently, 23 states and Puerto Rico are eligible to compete for COBRE or INBRE grants. Marshall University was awarded an INBRE grant as the lead institution in 2004 with West Virginia University serving as a partner lead institution.  Dr. Gary Rankin, Professor and Chair of the Department of Pharmacology, Physiology and Toxicology at Marshall University is the Principal Investigator for the WV-INBRE program.

Dr. Travis Salisbury featured in the Neuron for cancer and obesity research

Dr. Travis Salisbury, an Assistant Professor in the Department of Pharmacology, Physiology and Toxicology, was featured in the Spring 2012 issue of the Neuron for his research into the link between cancer and obesity.

Dr. Salisbury was recently awarded a $60,000 grant from Pharmaceutical Research and Manufacturers of America Foundation to further his study.

The Neuron is a quarterly journal of science and research that contains features about research, researchers, and science-related news from West Virginia.

To read the story (featured on page four of the issue), download the pdf of the Spring 2012 issue of the Neuron:
http://www.wvresearch.org/wp-content/uploads/2012/04/Spring-Neuron-2012.pdf.

BMS Program celebrates Seventh Annual Biomedical Sciences Research Retreat

Students attending the research retreatOn August 19, the faculty, staff, and students of the Biomedical Sciences (BMS) Graduate Program gathered together for the Seventh Annual Biomedical Sciences Research Retreat. Held at the Ramada Limited in Huntington, the retreat served as an excellent opportunity to socialize in an informal setting over a tasty lunch, share research projects and advancements, welcome a guest alumni speaker, and present awards for outstanding service and research. Dr. Elsa Mangiarua organized the event, as she does every year. Thanks to her guidance the event, as always, went smoothly and was a great success.

The event began with a buffet lunch, followed by time to mingle and view research posters. After lunch, a lively discussion commenced as research students and faculty members discussed their research projects with each other. Although this is a small group that interacts frequently, events such as this still evoke quite a bit of exchange and interest.

George Kamphaus, Ph.D.The poster presentations were followed by a seminar delivered by Dr. George Kamphaus, a graduate of the Biomedical Sciences Ph.D. Program who completed a Post-Doc at Harvard. He delivered a seminar entitled “Fc-Fusion of Clotting Factor IX: Development of a Long-acting Clotting Factor.” Dr. Kamphaus is currently a Senior Scientist working for Syntonix Pharmaceuticals. There is currently only one drug on the market targeted to treated Hemophilia B, and his company is working diligently to change this fact. Currently, Hemophilia B patients must receive injections of this drug twice weekly to treat their disease. The drug that Syntonix is developing is a clotting factor that has a longer duration of action, enabling patients to instead receive weekly injections. According to Dr. Kamphaus, there are patients in India suffering from this condition who must currently travel more than 12 hours to receive their injections; a drug that can be injected once weekly will make a significant difference in the lives of such patients.

During his seminar, Dr. Kamphaus spoke highly of the BMS Ph.D. Program, expressing that it prepared him well for a career in the pharmaceutical industry. Unlike more established academic programs that may employ a silo structure, pharmaceutical companies are often smaller start-ups that require researchers to frequently interact. According to Dr. Kamphaus, the interdisciplinary nature of the BMS Program prepared him well for this. He also spoke fondly of the level of concern from BMS Program instructors: “They care about their students, and this really comes across. The individual attention to students is extraordinary, and much different than what you would find in other programs. I think this sets up BMS graduates well for success.”

After the seminar, a representative from each research cluster delivered a short presentation covering current cluster research. Ben Owen, a Ph.D. student in the Neuroscience and Developmental Biology Cluster, discussed his research on action potentials; Aileen Marcelo, a Ph.D. Candidate in the Cardiovascular Disease, Obesity, and Diabetes Cluster, spoke of her work focusing on VEGF; Johannes Fahrmann, a Ph.D. Student in the Cancer Biology Cluster, discussed the effects of omega-3 fatty acids on downregulating NFkB within early-stage chronic lymphocytic leukemia; Dr. Gary Rankin of the Toxicology and Environmental Health Sciences Cluster updated the group on his work on genetic polymorphisms and unexpected methodone mortality; and Dr. Wei-ping Zeng of the Infectious and Immunological Diseases Cluster elaborated on his work with CD4 T cell differentiation.

Paula KounsThe cluster updates were followed by the presentation of awards for the 2010-2011 school year. Miranda Carper, President of the BMS GSO, presented the faculty awards. Awards were given to Dr. Travis Salisbury for Faculty Appreciation and Paula Kouns for Staff Appreciation. Dr. Salisbury was lauded for his accessibility to students. A student who nominated Dr. Salisbury remarked, “I appreciate the fact that he talks to me like an equal or a colleague.” In praise of Paula Kouns, another student stated: “Outside of being a genuinely nice and caring person, Paula goes above and beyond as our department secretary.”

 

Dr. Richard Niles presented the graduate student awards. The following students received awards: 

Sunil Kakarla, Ph.D. candidateBest Research Performance (Plaque and a paid trip to a national meeting up to $2,000): Sunil Kakarla

 

 

 

 

Anne Silvis, Ph.D. candidateBest Overall Performance as a Graduate Student (Plaque and a paid trip to an international meeting, up to $3,500): Anne Silvis

 

 

 

 

Highest GPA for a First Year Medical Sciences student (Plaque): Ross DeChant, Brittany Wall

Highest GPA for a First Year Research student (Plaque): Steven Rogers

Lotspeich Award ($1,000): Jesse Thornton

Best Creative Title for the Inaugural Issue of the BMS Magazine ($100): Miranda Carper

Thank you to our participants, speakers and award-winners. Also, a big thank you goes out to Dr. Mangiarua for doing such a great job in organizing the event! We look forward to seeing everyone at the gathering again next year.